Publication | Closed Access

Long-term Follow-up After Conversion from Intravenous Epoprostenol to Oral Therapy With Bosentan or Sildenafil in 13 Patients With Pulmonary Arterial Hypertension

HypertensionPulmonary Arterial HypertensionCardiovascular DiseaseMedicineAntihypertensive TherapyCardiovascular PharmacologyPharmacotherapyIntravenous EpoprostenolPublic HealthPharmacologyLong-term Follow-upPulmonary Vascular DiseaseAnesthesiology